Sarah Fakih | executive |
Alexander Zehnder | executive |
Myriam Mendila | executive |
Pierre Kemula | executive |
Boran Wang | analyst |
Marcus Dalton | executive |
Eliana Merle | analyst |
Eun Yang | analyst |
Analyst | analyst |
Chen Yang | analyst |
Greetings, and welcome to the CureVac Financial Results for Third Quarter and First 9 Months of 2023 business update. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Sarah Fakih, Vice President of Corporate Communications and Investor Relations. Thank you, Sarah, you may begin.
Thank you.